Cargando…
Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management
Immunotherapy is one of the most recent systemic treatments to emerge for use in oncology, and is based on the blocking of inhibitory immune checkpoints to potentiate the immune response to cancer. The anti-cytotoxic T lymphocyte-associated antigen-4 antibody ipilimumab and anti-programmed cell deat...
Autores principales: | Stucci, Stefania, Palmirotta, Raffaele, Passarelli, Anna, Silvestris, Erica, Argentiero, Antonella, Lanotte, Laura, Acquafredda, Silvana, Todisco, Annalisa, Silvestris, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661371/ https://www.ncbi.nlm.nih.gov/pubmed/29113194 http://dx.doi.org/10.3892/ol.2017.6919 |
Ejemplares similares
-
Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family
por: Palmirotta, Raffaele, et al.
Publicado: (2018) -
SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
por: Palmirotta, Raffaele, et al.
Publicado: (2018) -
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
por: Marco, Tucci, et al.
Publicado: (2019) -
Nutrition and Female Fertility: An Interdependent Correlation
por: Silvestris, Erica, et al.
Publicado: (2019) -
DEAD-Box Helicase 4 (Ddx4)(+) Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers
por: D’Oronzo, Stella, et al.
Publicado: (2020)